Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the efficacy of Viagra dose titration to 100mg versus 50mg in men with erectile dysfunction, based on responses to the IIEF questionnaire as measured at the beginning and at the end of double blind treatment, comparing the group titrated to 100mg vs. the group maintained on 50mg.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sildenafil | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Change in IIEF erectile function domain score at the end of double blind treatment. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in other IIEF domain scores; Response to other questionnaires regarding treatment satisfaction, safety and tolerability. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Kitchener | Ontario | Canada | |||
| Pfizer Investigational Site |
Not provided
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Sarnia |
| Ontario |
| Canada |
| Pfizer Investigational Site | Toronto | Ontario | Canada |
| Pfizer Investigational Site | Saint-Léonard | Quebec | Canada |
| Pfizer Investigational Site | Trois-Rivières | Quebec | Canada |
| Pfizer Investigational Site | Lille | France |
| Pfizer Investigational Site | Lyon | France |
| Pfizer Investigational Site | Montpellier | France |
| Pfizer Investigational Site | Paris | France |
| Pfizer Investigational Site | Goudi | Athens | Greece |
| Pfizer Investigational Site | Pátrai | Greece |
| Pfizer Investigational Site | Thessaloniki | Greece |
| Pfizer Investigational Site | Beersheba | Israel |
| Pfizer Investigational Site | Haifa | Israel |
| Pfizer Investigational Site | Petah Tikva | Israel |
| Pfizer Investigational Site | Tel Aviv | Israel |
| Pfizer Investigational Site | Bologna | Italy |
| Pfizer Investigational Site | Florence | Italy |
| Pfizer Investigational Site | L’Aquila | Italy |
| Pfizer Investigational Site | Milan | Italy |
| Pfizer Investigational Site | Roma | Italy |
| Pfizer Investigational Site | Moscow | Russia |
| Pfizer Investigational Site | San Cristóbal de La Laguna | Santa Cruz De Tenerife | Spain |
| Pfizer Investigational Site | Alicante | Spain |
| Pfizer Investigational Site | Barcelona | Spain |
| Pfizer Investigational Site | Madrid | Spain |
| Pfizer Investigational Site | Málaga | Spain |
| Pfizer Investigational Site | Seville | Spain |
| Pfizer Investigational Site | Valencia | Spain |
| Pfizer Investigational Site | Belmont | Durham | United Kingdom |
| Pfizer Investigational Site | Ashford | Middlesex | United Kingdom |
| Pfizer Investigational Site | Weybridge | Surrey | United Kingdom |
| Pfizer Investigational Site | Chippenham | Wilts. | United Kingdom |
| Pfizer Investigational Site | Trowbridge | Wiltshire | United Kingdom |
| Pfizer Investigational Site | Bath | United Kingdom |
| Pfizer Investigational Site | Coventry | United Kingdom |
| Pfizer Investigational Site | Doncaster | United Kingdom |
| Pfizer Investigational Site | Dundee | United Kingdom |
| Pfizer Investigational Site | Glasgow | United Kingdom |
| ID | Term |
|---|---|
| D007172 | Erectile Dysfunction |
| ID | Term |
|---|---|
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D012735 | Sexual Dysfunction, Physiological |
| D052801 | Male Urogenital Diseases |
| D020018 | Sexual Dysfunctions, Psychological |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D000068677 | Sildenafil Citrate |
| ID | Term |
|---|---|
| D013449 | Sulfonamides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D013450 | Sulfones |
| D013457 | Sulfur Compounds |
| D010879 | Piperazines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D011687 | Purines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
Not provided
Not provided